Search Within

Joachim Yahalom

  1. "Journal of Clinical Oncology"
Formats
  1. Journal Article (30)
  2. Meeting Abstract (16)
Groups
  1. Radiation Oncology, Department of (46)
  2. Survivorship Research (46)
  3. Department of Medicine (19)
  4. Hematologic Malignancies, Division of (19)
  5. Center for Hematologic Malignancies (16)
  6. Epidemiology and Biostatistics (15)

More Groups

People
  1. Lisa De Angelis (13)
  2. Lauren Abrey (12)
  3. Andrew Zelenetz (9)
  4. David Straus (9)
  5. Craig Moskowitz (8)
  6. Ariela Noy (7)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2021 (2)
  4. 2020 (2)
  5. 2018 (2)
  6. 2017 (1)

More Years

Publications
  1. Journal of Clinical Oncology (46)
Publishers
  1. American Society of Clinical Oncology (46)

Results (46)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of nivolumab plus doxorubicin, vinblastine, dacarbazine as frontline therapy in older adults with Hodgkin lymphoma
    Journal Article

    Torka, P.; Feldman, T.; Savage, K. J.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Capadona, C.; Subzwari, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Combined modality for localized gastric diffuse large B-cell lymphoma: Long-term outcomes of 50 patients
    Meeting Abstract

    Fregonese, B.; Imber, B. S.; Dreyfuss, A.; Boe, L. A.; Hajj, C.; Yahalom, J.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Shah, G.; Schòˆder, H.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Ryu, S.; Sohail, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Brentuximab vedotin combined with chemotherapy in patients with newly diagnosed early-stage, unfavorable-risk Hodgkin lymphoma
    Journal Article

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, E.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Constine, L. S.; Dandapani, S. V.; Drill, E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Impact of interim PET on Hodgkin lymphoma treatment outcome and survival in clinical practice
    Meeting Abstract

    Zheng, S.; Gupta, K.; Goyal, P.; Nakajima, R.; Michaud, L.; Batlevi, C. L.; Hamlin, P. A.; Horwitz, S. M.; Kumar, A.; Matasar, M. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Early data from a phase II trial investigating the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Sermer, D. J.; Vardhana, S. A.; Ames, A.; Biggar, E.; Moskowitz, A. J.; Batlevi, C. L.; Caron, P.; Hamilton, A. M.; Moskowitz, C. H.; Matasar, M. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • The outcome of patients with non-chemosensitive relapsed and refractory DLBCL salvaged with radiation therapy followed by autologous stem cell transplant
    Meeting Abstract

    Yang, J. C.; Chau, K.; Scordo, M.; Sauter, C. S.; Yahalom, J.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Early-stage follicular lymphoma: What is the preferred treatment strategy?
    Journal Article

    Yang, J. C.; Yahalom, J.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Cost-effectiveness analysis of first-line treatments for early-stage, low-grade follicular lymphoma
    Meeting Abstract

    Yang, J. C.; Elkin, E. B.; Parikh, R.; Yahalom, J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Re-examining the role of radiation therapy for diffuse large B-cell lymphoma in the modern era
    Journal Article

    Ng, A. K.; Dabaja, B. S.; Hoppe, R. T.; Illidge, T.; Yahalom, J.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save